Results 191 to 200 of about 1,742,061 (410)
Serum Polysaccharide and Fever in Thrombocytopenic Bleeding of Leukemia [PDF]
GUSTAVE FREEMAN, EDWARD S. BUCKLEY
openalex +1 more source
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
A. Roberts+18 more
semanticscholar +1 more source
Glucose deprivation or GLUT1 inhibition induces disulfidptosis in SLC7A11high ovarian cancer cells by promoting cystine accumulation, NADPH/ATP depletion, and F‐actin disulfide formation. SLC7A11 interacts with INF2 to further increase H₂O₂ levels and impair mitochondrial fission, suppressing cell migration. Targeting the SLC7A11–INF2 axis represents a
Zhenyu Song+9 more
wiley +1 more source
Polycythemia Vera Terminating with Myeloblastic Leukemia [PDF]
Marjorie J. Williams, Julius L. Mendel
openalex +1 more source
This study identifies a novel oncogenic role and a previously unrecognized phosphorylation substrate of BCKDK in RCC, wherein it promotes tumor progression and drug resistance through AKT phosphorylation at both Thr308 and Ser473 sites and activation of AKT/mTOR and AKT/ABCB1 signaling pathways, offering a promising prognostic marker and therapeutic ...
Qin Tian+18 more
wiley +1 more source
Radioactive phosphorus. II. In the treatment of myeloid leukemia [PDF]
Henry D. Diamond, Lloyd F. Craver
openalex +1 more source
Analysis of global, regional, and national burden and attributable risk factors of acute lymphoblastic leukemia and acute myeloid leukemia from 1990 to 2021. [PDF]
Ni H, Shi Y, Wang M, Ji C.
europepmc +1 more source
In this study, Acod1 knockout in CLP mice significantly increases peripheral blood NET levels, exacerbating inflammation, organ damage, and reducing survival. Further research shows that UBR5 interacts with PAD4, a key NET formation protein. Acod1/itaconate (ITA) enhances the enzymatic activity of UBR5 by alkylating the Cys2768 site, promoting the K48 ...
Huifan Liu+10 more
wiley +1 more source